Synonym: Anti-CaI-PLA2, Anti-GVI, Anti-INAD1, Anti-IPLA2-VIA, Anti-PARK14, Anti-PLA2, Anti-PLA2G6, Anti-PNPLA9, Anti-Phospholipase A2, group VI (cytosolic, calcium-independent), Anti-iPLA2
MDL number MFCD00803786
Popular Documents: Datasheet (PDF)
| Related Categories | Alphabetical Index, Antibodies, Antibodies for Cell Biology, Antibodies for Parkinson’s Disease Research, Antibodies to Lipids in Cell Signaling, |
| species reactivity | human, mouse, rat |
| application(s) | western blot: 1.5-3.0 μg/mL using using extracts of HEK-293T cells overexpressing human iPLA2, RAW264 cell lysates and rat pancreas extracts (S1 fraction). |
| clone | polyclonal |
| concentration | ~1.5 mg/mL |
| antibody form | affinity isolated antibody |
| form | buffered aqueous solution |
| mol wt | mol wt ~85 kDa ( and ~95 kDa human iPLA2 and ~95 kDa mouse and rat iPLA2.) |
| shipped in | dry ice |
| storage temp. | −20°C |
| Gene Information |
human ... PLA2G6(8398) mouse ... pla2g6(53357) rat ... pla2g6(360426) |
synthetic peptide corresponding to amino acids 541-558 of human iPLA2, conjugated to KLH. The corresponding sequence is identical in mouse and rat iPLA2.
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?